Knight Therapeutics Inc., (TSX: GUD) ('Knight') a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda. has received approval from ...

One of Central America's most important recent developments is unfolding in a less visible but more tangible area for citizens: access to medicines.

Chief Executive Officer — Dr. Sergio Traversa Chief Medical Officer, Oncology — Dr. Raj S. Pruthi Chief Financial Officer — Maged S. Shenouda With me on today's call are Relmada Therapeutics, Inc.'s ...

Thank you, Hilla, and welcome to IceCure Medical Ltd's conference call to review the financial results as of and for the twelve months ended December 31, 2025, and provide an update on recent ...

The Trump administration recently celebrated one year of embracing the movement to Make America Healthy Again. Unfortunately, ...

Rachel Papka explains why healthcare contact centers shape patient anxiety, access and trust long before a clinician enters ...

Title X is a 56-year-old federal grant program that supports thousands of clinics that provide birth control and STI testing and treatment around the country. Now those clinics could face a funding ...

President Trump’s push to pass the Safeguard American Voter Eligibility (SAVE) America Act is taking center stage this week in the Senate, where it faces an uphill battle amid unified Democratic ...

Health and Human Services Secretary Robert F. Kennedy Jr., who founded an antivaccine group and once likened the immunization of children to a holocaust, is transforming a government that long ...

A trio of Oklahoma teenagers are suing Elon Musk’s xAI, accusing the company’s artificial intelligence program of stealing images of them off the internet to create child pornography. The lawsuit, ...

U.S. cigarette smoking hits a record low as vaping stays widespread and nicotine pouch use grows, reshaping public health and tobacco policy.

A generation of kids got their first taste of freedom on the Big Wheel. It almost didn't survive the whims of corporate ...